BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2153347)

  • 1. Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction.
    Domagala W; Lasota J; Bartkowiak J; Weber K; Osborn M
    Am J Pathol; 1990 Jan; 136(1):219-27. PubMed ID: 2153347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of proliferative rate of breast cancer by Ki-67 monoclonal antibody.
    Marchetti E; Querzoli P; Marzola A; Bagni A; Ferretti S; Fabris G; Nenci I
    Mod Pathol; 1990 Jan; 3(1):31-5. PubMed ID: 2308919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vimentin is preferentially expressed in high-grade ductal and medullary, but not in lobular breast carcinomas.
    Domagala W; Woźniak L; Lasota J; Weber K; Osborn M
    Am J Pathol; 1990 Nov; 137(5):1059-64. PubMed ID: 2173410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vimentin expression appears to be associated with poor prognosis in node-negative ductal NOS breast carcinomas.
    Domagala W; Lasota J; Dukowicz A; Markiewski M; Striker G; Weber K; Osborn M
    Am J Pathol; 1990 Dec; 137(6):1299-304. PubMed ID: 1701960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of expression of androgen receptor may play a critical role in transformation from in situ to invasive basal subtype of high-grade ductal carcinoma of the breast.
    Hanley K; Wang J; Bourne P; Yang Q; Gao AC; Lyman G; Tang P
    Hum Pathol; 2008 Mar; 39(3):386-92. PubMed ID: 18187183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a basal-like subtype of breast ductal carcinoma in situ.
    Livasy CA; Perou CM; Karaca G; Cowan DW; Maia D; Jackson S; Tse CK; Nyante S; Millikan RC
    Hum Pathol; 2007 Feb; 38(2):197-204. PubMed ID: 17234468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen and progesterone receptor and c-erbB-2 oncoprotein analysis in pure in situ breast carcinoma: an immunohistochemical study.
    Wilbur DC; Barrows GH
    Mod Pathol; 1993 Mar; 6(2):114-20. PubMed ID: 8097877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vimentin--a new prognostic parameter in breast carcinoma?
    Raymond WA; Leong AS
    J Pathol; 1989 Jun; 158(2):107-14. PubMed ID: 2547048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
    de Candia P; Akram M; Benezra R; Brogi E
    Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study.
    Bircan S; Kapucuoglu N; Baspinar S; Inan G; Candir O
    Pathol Res Pract; 2006; 202(8):569-76. PubMed ID: 16828238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters.
    Naidu R; Wahab NA; Yadav MM; Kutty MK
    Oncol Rep; 2002; 9(2):409-16. PubMed ID: 11836618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vimentin and alpha-fetoprotein expression in breast cancer smears: relationship with various prognostic factors.
    Athanassiadou P; Lazaris D; Athanassiades P; Kyrkou K; Petrakakou E; Keramopoulos K; Aravantinos D
    Cancer Detect Prev; 1997; 21(3):207-12. PubMed ID: 9167037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical study of TGF-alpha, TGF-beta1, EGFR, and IGF-1 expression in human breast carcinoma.
    Pilichowska M; Kimura N; Fujiwara H; Nagura H
    Mod Pathol; 1997 Oct; 10(10):969-75. PubMed ID: 9346175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant P-cadherin expression: is it associated with estrogen-independent growth in breast cancer?
    Paredes J; Milanezi F; Reis-Filho JS; Leitão D; Athanazio D; Schmitt F
    Pathol Res Pract; 2002; 198(12):795-801. PubMed ID: 12608656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical demonstration of cell proliferation and estrogen receptor status in human breast cancer. Analysis of 45 cases.
    Hori M; Furusato M; Nikaidoh T; Aizawa S
    Acta Pathol Jpn; 1990 Dec; 40(12):902-7. PubMed ID: 1965755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
    Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression.
    Umemura S; Takekoshi S; Suzuki Y; Saitoh Y; Tokuda Y; Osamura RY
    Oncol Rep; 2005 Aug; 14(2):337-43. PubMed ID: 16012712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.